Cancer Research Funding

Share

Cancer Survivors

Cancer Research

Cancer research saves lives and makes more time for survivors.

By investing in the research of today, Congress can help prevent, detect, and treat many of the cancers of tomorrow, creating countless moments for patients and their loved ones in the process.

Every major breakthrough in the fight against cancer has one thing in common: the research was in some way funded by the federal government's National Institutes of Health and the National Cancer Institute.

Increased funding for cancer research lengthens and saves lives and must be a top budget priority for Congress.
 

Take Action

Male Volunteer Disapproving
National

President's budget proposal falls short for cancer patients.

The president released his annual budget proposal calling for cuts to research funding. We can't afford to stand still in the fight against cancer. Contact your member of Congress and urge them to invest in cancer research.

Contact your member of Congress today
National

Congress: Protect and Increase Lifesaving Cancer Research Funding

Ending cancer as we know it, for everyone, starts in Congress and sustained funding for lifesaving cancer research. Send a message to your members of Congress today and urge them to prioritize the fight against cancer. 

Send a Message to your Member of Congress
National

How has cancer research funding impacted you?

Stories help demonstrate why cancer research funding is so important. If you've been impacted by advancements in cancer research or recent cuts to clinical trials, we want to hear from you.

Share Your Story Today

Latest Updates

See More Updates

Sweeping Changes in Grantmaking Could Jeopardize the Future of Cancer Research and the Country’s Global Leadership in Biomedical Innovation

June 9, 2026
National

In late May, the Office of Management and Budget (OMB) released a proposed rule that would fundamentally change how federal grants and contracts would be awarded and managed, opening the door for interference and jeopardizing federal research investments. These changes would affect work funded by the National Institutes

House Committee Considers FY27 Appropriations Bill with Boost to Cancer Research and Prevention Funding

June 9, 2026
National

Today, the House Committee on Appropriations considered and approved its draft FY27 appropriations bill and accompanying House Report that includes increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Center for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC).

Alabama Cancer Researcher to Travel to Capitol Hill to Urge Continued Federal Investment in Cancer Research

May 19, 2026
Alabama

WASHINGTON, D.C. – Cancer survivors, researchers and advocates, including Lynne Nacke of Birmingham, will travel to Capitol Hill on May 21 to deliver a message to Congress: America’s progress against cancer is working but continued investment is essential to save more lives. The advocates represent researchers developing the next

South Carolina Cancer Researcher to Travel to Capitol Hill to Urge Continued Federal Investment

May 18, 2026
South Carolina

WASHINGTON, D.C. – Cancer survivors, researchers and advocates, including Dr. Ian Padykula of Johns Island, will travel to Capitol Hill on May 21 to deliver a message to Congress: America’s progress against cancer is working but continued investment is essential to save more lives. The advocates represent researchers developing

Cancer Research Funding Resources

Drug Pricing Reform Proposals: Considerations for Cancer Care

September 10, 2025

Drug therapies are the bedrock of cancer care. Making these therapies affordable, while continuing to encourage innovation of new treatments, is crucial to accomplishing the mission of the American Cancer Society Cancer Action Network (ACS CAN) to end cancer as we know it, for everyone. ACS CAN has long fought for public policies that support both the affordability and availability of medically necessary prescription drugs. 
 

ACS CAN Supports the Clinical Trial Modernization Act (H.R. 3521 / S. 4440)

May 22, 2025

The Clinical Trial Modernization Act (H.R. 3521 / S. 4440) increases access to clinical trials by allowing clinical trial sponsors to provide financial support to patients for costs associated with their trial participation, including medical cost-sharing like copays, and non-medical expenses such as travel, parking, food and lodging.

ACS Comments on NIH Modernization Proposal

August 16, 2024

The House Energy and Commerce Committee sought community feedback on potential structural and policy changes at the National Institutes of Health.  ACS CAN offered suggestions related to NCI and the proposal's impacts on cancer research.